Molecule Details
InChIKeyAQHHHDLHHXJYJD-UHFFFAOYSA-N
Compound NamePropranolol
Canonical SMILESCC(C)NCC(O)COc1cccc2ccccc12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)11
Pfam Stratification Cross-Family
Avg pChEMBL7.06
SourceChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00571
Drug NamePropranolol
CAS Number525-66-6
Groups approved investigational
ATC Codes C07FX01 C07AA05 C07BA05
DescriptionPropranolol is a racemic mixture of 2 enantiomers where the S(-)-enantiomer has approximately 100 times the binding affinity for beta adrenergic receptors.[L6904] Propranolol is used to treat a number of conditions but most commonly is used for hypertension.[L6901,L6904,L6907] Propranolol was grante...

Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic beta-Antagonists Agents causing hyperkalemia Alcohols Amines Amino Alcohols Antiarrhythmic agents Antihypertensive Agents Antihypertensive Agents Indicated for Hypertension Beta Blocking Agents and Thiazides Beta Blocking Agents, Non-Selective Beta Blocking Agents, Non-Selective, and Thiazides Bradycardia-Causing Agents Cardiovascular Agents Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (weak) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Hypotensive Agents Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates Naphthalenes Negative Inotrope Neurotransmitter Agents OCT2 Inhibitors P-glycoprotein inhibitors P-glycoprotein substrates Phenoxypropanolamines Propanolamines Propanols QTc Prolonging Agents Vasodilating Agents
Cross-references: BindingDB: 25761 ChEBI: 8499 CHEMBL27 ChemSpider: 4777 Drugs Product Database (DPD): 10127 Guide to Pharmacology: 564 IUPHAR: 564 C07407 D08443 PharmGKB: PA451145 PubChem:4946 PubChem:46505387 RxCUI: 8787 Therapeutic Targets Database: DAP000089 Wikipedia: Propranolol
Target Activities (11)
Target Gene Organism Category Pfam pChEMBL Type Source
P07550 ADRB2 Homo sapiens Human PF00001 8.9 Kd ChEMBL
P08588 ADRB1 Homo sapiens Human PF00001 8.6 Kd ChEMBL
P13945 ADRB3 Homo sapiens Human PF00001 8.4 Kd ChEMBL
Q99720 SIGMAR1 Homo sapiens Human PF04622 7.0 Ki ChEMBL
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.6 IC50 ChEMBL
P41595 HTR2B Homo sapiens Human PF00001 6.6 IC50 ChEMBL
Q5BJF2 TMEM97 Homo sapiens Human PF05241 6.5 Ki ChEMBL
P28223 HTR2A Homo sapiens Human PF00001 6.4 Ki ChEMBL
Q9Y466 NR2E1 Homo sapiens Human PF00104 PF00105 6.3 Kd ChEMBL
P50406 HTR6 Homo sapiens Human PF00001 6.3 Ki ChEMBL
P08908 HTR1A Homo sapiens Human PF00001 6.2 Ki ChEMBL
DrugBank Target Actions (18)
Target Gene Target Name Action Type
P02763 P02763 Alpha-1-acid glycoprotein 1 binder carriers
P02768 ALB Albumin binder carriers
P04798 CYP1A1 Cytochrome P450 1A1 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P21397 MAOA Amine oxidase [flavin-containing] A inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P24462 CYP3A7 Cytochrome P450 3A7 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P07550 ADRB2 Beta-2 adrenergic receptor antagonist targets
P08588 ADRB1 Beta-1 adrenergic receptor antagonist targets
P13945 ADRB3 Beta-3 adrenergic receptor antagonist targets
P08908 HTR1A 5-hydroxytryptamine receptor 1A other/unknown targets
P28222 HTR1B 5-hydroxytryptamine receptor 1B other/unknown targets
O15244 SLC22A2 Solute carrier family 22 member 2 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters